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identified 295 spinal injury patients, with a mean age at index of 44 years, an
average follow-up time of 6 years, and of which 79% were males. For 67% of the
population we observed at least one UTI, which resulted in a care contact. Inter-
estingly, a quarter of the population used prophylactic antibiotics (J01XX05), cor-
responding to an average of 235 DDDs per year, amongst users. A majority of UTIs
were handled in primary care, while over 90% of costs were contributed by UTI-
related hospitalisations. The mean cost per UTI was 43,500 SEK, while estimates
varied considerably, with costs ranging from an average of 1,800 SEK for UTIs
handled in primary care to 177,200 SEK for inpatient care. CONCLUSIONS: In a
population of spinal injury patients, costs for catheter-associated urinary tract
infections are to a large extent driven by outlier, expensive hospitalisation. There
would be a large potential for cost savings if these hospitalisations could be
avoided.
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OBJECTIVES: To collect real-life data on costs and resource use, in order to under-
stand the economic burden of urinary tract infection (UTI) amongst a population
who has received self- catheterisation training. METHODS: We used the CEBRxA
database, which combines data from a public claims database for the South-West
region of Sweden, comprising around 1.5 million individuals, with national Swed-
ish registers on drug utilisation and mortality. We identified a population of pa-
tients who had received self-catheterisation training anytime between 2006 and
2009(procedure code GB005). UTIs were identified through the following ICD-10
codes: N11.0, N30*, N39.0*, N39.X*, N12.-P, and N30.-P. A cost per UTI was calculated
through considering UTI-related care contacts that occurred within 14 days from
each other. RESULTS: We identified 989 patients, with a high mean age at index of
65 years, 79% males, and an average follow-up time of 1.5 years. The disease burden
of this population was mainly related to the genitourinary system, like retention of
urine, benign prostate hyperplasia, cystitis, and neurogenic bladder, although es-
sential hypertonia emerged as the third most common comorbidity. We observed
an average frequency of one UTI every two years, while around one-fifth of patients
had a yearly UTI-frequency of one or above. A majority of UTIs were handled in
primary care, while around 80% of costs were contributed by UTI-related hospitali-
sations. However, among female patients, inpatient care only contributed to 60% of
total costs. The mean cost per UTI was 10,500 SEK, while estimates varied, with
average costs ranging from 2,100 SEK in primary care, to 32,000 SEK for inpatient
care. CONCLUSIONS: Patients having received self-catheterisation training were
on average of higher age and male. UTI-related hospitalisation was a clear driver of
costs, although this effect was less pronounced for women.
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OBJECTIVES:Approximately 880,000 tonsillectomy/adenoidectomy procedures are
performed in the US annually. Hemostatic matrix (FLOSEAL) is used for adjunctive
hemostasis in a variety of surgeries, but the health economic rationale supporting
its application in tonsillectomy and adenoidectomy has yet to be established. A
systematic literature review was conducted in order to examine the evidence for
hemostatic matrix and to consider its value in reducing the burden of these
procedures. METHODS: Applying keywords and inclusion criteria, the PubMed,
EMBASE, and Centre for Reviews and Dissemination databases were queried for
studies published in English up to March 1, 2011. Reference lists and the American
Academy of Otolaryngology-Head and Neck Surgery database were also manually
searched. Data on costs, resource utilization, and health outcomes were extracted
and summarized. RESULTS: Four prospective, randomized controlled trials pro-
vided data on 187 patients treated with hemostatic matrix. In the two studies
utilizing crossover design, no patients in the hemostatic matrix groups required
electrocautery, whereas 3 of 35 (9%) and 4 of 34 (12%) patients, respectively, re-
quired adjunctive hemostatic matrix intraoperatively after failing electrocautery.
In all three studies measuring operating room time, use of hemostatic matrix re-
sulted in significantly shorter mean durations (range, 0.93 to 24.6 minutes) com-
pared to electrocautery (range, 9.53 to 32.6 minutes) (all studies, P0.05). Although
postoperative bleeding rates did not differ, hemostatic matrix-treated patients in
three of four studies reported significant reductions in postoperative pain scores
and narcotic consumption compared to electrocautery-treated patients (P0.05).
CONCLUSIONS: Published evidence suggests that hemostatic matrix is effective in
achieving intraoperative hemostasis during tonsillectomy/adenoidectomy. Given
the high volume of procedures, using hemostatic matrix during tonsillectomy and
adenoidectomy may be potentially cost saving due to resulting reductions in oper-
ating time and postoperative narcotic consumption. Further research may identify
patients who are more likely to benefit from hemostatic matrix in this indication.
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DATA VISUALIZATION FOR BUSINESS INTELLIGENCE: ASSESSING AN ONLINE
TOOL USED FOR BENCHMARKING HOSPITAL PROCEDURE COSTS TO
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OBJECTIVES: Data visualization as a form of business intelligence and knowledge
discovery will democratize the use of large scale payer/claims and electronic med-
ical records databases. The goal of this analysis was to assess the feasibility of
utilizing Tableau Software™ to create a data visualization tool that would augment
data mining and analytic methods for understanding hospital costs and reim-
bursement patterns in cardiac catheterization and electrophysiology procedures.
METHODS: The Premier Perspective® database was utilized for this analysis. The
Premier Perspective® database houses data from over 600 hospitals and ambula-
tory surgery centers across the United States. Eligible procedures were those that
occurred during the year 2010 with the associated ICD-9 or CPT codes for either
cardiac catheterization or electrophysiology procedures. All data were imported
into Tableau Software™ and dashboards were created to visualize the data by
procedure costs and department costs. Summary statistics of hospital utilization,
total costs, components of costs, and hospital charges for both inpatient and out-
patient settings are available for exploration in a dynamic manner by each quarter
in 2010. Each dashboard is hosted in a secure online environment and fully inter-
active allowing for dozens of different filters to be applied. RESULTS: For the year
2010 there were 1,104,936 visits of cardiac related procedures With 164,210 unique
cardiac catheterization procedures and 22,263 cardiac electrophysiology proce-
dures. Custom developed dashboards show procedures (and associated volumes)
by in- and out- patient status, by ICD-9 or CPT code, department, costs and CMS
reimbursement levels. This data visualization tool makes it possible to quickly see
hospital cost breakdowns on dozens of different dimensions. CONCLUSIONS: Tab-
leau Software™ is a powerful tool to enable the health outcomes researcher to have
insights into complex multilevel data. Business intelligence tools developed in this
manner enable visual interaction and exploration of data for rapid hypothesis
generation and business intelligence.
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OBJECTIVES: Patients suffering from ALS have a need for a multitude of medical
aids. Existing (bureaucratic) hurdles might create plenty of problems for people
with rare diseases. Uncertainty about provision of medical aids and substantial
waiting times limit patient’s ability to participate in the activities of daily living.
This study aims 1) to analyze problems in financing and provision of medical aids;
2) to explore differences in reimbursement decisions of private and social health
insurance (SHI); and 3) to explore patient satisfaction according to the type of
health insurance. METHODS: First, published and grey literature was used to anal-
yse payment flows and supply chain activities of the various actors involved in the
provision and payment of medical aids. Second, a survey of ALS patients (n20)
based on semi-standardized questionnaires was conducted . Gathered information
included patients’ demographic characteristics, information on coverage decisions
and problems in the provision of medical aids. Based on patient satisfaction, anal-
ysis of variance tests were performed to investigate differences in satisfaction
between SHI and privately insured persons. RESULTS: A majority of patients expe-
rienced problems in reimbursement decisions, particularly in the case of expensive
or individually customized technologies. These reimbursement problems were
more common among SHI insured persons. Both SHI insured and privately insured
persons complain about long duration processes of individual requests for meeting
the cost. Nonetheless, most patients stated that they were satisfied with the actual
provision of medical aids, including product and service quality. CONCLUSIONS:
Our results suggest that difficulties with medical aids’ reimbursement decision
processes are a common problem among SHI and private insured ALS patients.
Although the patient’s insurance type has an impact on these time-consuming
process. Consequently, there is a need for an interdisciplinary approach in the
provision of medical aids. Case managers might be a solution to overcome these
problems.
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COMPLICATED PARKINSON’S DISEASE: DISCRETE CHOICE ANALYSIS TO
ASSESS PATIENTS’ PREFERENCES. A PILOT STUDY
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OBJECTIVES: In advanced or complicated Parkinson’s disease (CPD), among other
treatment alternatives, patients can receive deep brain stimulation (DBS) or con-
tinuous duodenal levodopa-carbidopa infusion (CDLCI). This pilot study was de-
signed to understand the preferences of patients who face these treatment choices.
METHODS:Treatment attributes were identified based on a literature review, focus
groups with patients, caregivers, and interviews with clinicians. A discrete choice
experiment survey was developed, reviewed by clinicians and piloted with pa-
tients. Patients (potentially considering DBS or CDLCI) in Spain (n30) and the UK
(n10) completed the survey . Treatment attributes included surgery type, impact
on daily life, medication need, speech difficulties, movement control, dyskinesia,
and off-periods. Data were analyzed using a multi-level hierarchical logistic model.
RESULTS: Surgery type (DBS electric lead insertion in the brain vs CDLCI intraduo-
denal tube placement) was the most powerful predictor in the model, with a pref-
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erence for DBS over CDLCI (OR 8.02, 95% CI6.17-10.38). Avoiding deterioration in
movement was also important in determining treatment choice (OR0.67;
95%CI0.57-0.79) as was avoiding limitations on daily activities; (OR0.69;
95%CI0.54-0.88). CONCLUSIONS: CPD patients were able to engage in this quite
complex task to indicate their views regarding treatments. Participants had a pref-
erence for DBS surgery type. Maintaining movement and daily activities were also
important attributes. As the surgery attribute was a composite of both surgical
procedure and daily maintenance, further study is needed to identify which of
these aspects is the strongest predictor of patient preferences. Finally, a larger
study is needed to understand the importance of attributes for all the treatment
alternatives that can be offered to CPD patients
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OBJECTIVES: To develop and subsequently evaluate content validity of questions
assessing patient preference between two dry powder inhaler (DPI) devices (the
Handihaler and the Novel DPI) for the treatment of chronic obstructive pulmonary
disease (COPD), based on ease of use. METHODS: Initial COPD Device Preference
Questionnaire (CDPQ) items were designed to assess inhaler device preference
based on aspects of ease of use identified as important by COPD patients and
physicians during previous research. Two iterative rounds of semistructured, in-
depth interviews were conducted in adult patients currently receiving COPD med-
ication via the Handihaler. Initially, patients were asked to describe the actuation
of the Handihaler. Next, the features and steps required to operate the Novel DPI
were described, and participants were asked to demonstrate using an empty de-
vice. Cognitive debriefing of the CDPQ was then conducted. Patients completed and
evaluated five items, each phrased two different ways (beginning with “which. . .”
or “thinking. . .”). Round 1 interviews (n 8) gathered feedback on preferred phras-
ing and modifications required to improve the CDPQ. Round 2 interviews (n  8)
assessed modifications and gathered additional input to confirm content validity.
All interviews were recorded and transcribed for analysis. RESULTS: Round 1 in-
terviews resulted in addition of instruction detail, modification of questions based
on a clear preference for the “which” phrasing, and removal of two items (i.e.,
understanding how to use the device and number of steps involved in preparing
the device) deemed duplicative. Round 2 interviews did not result in additional
changes. Participants found instructions, items, and response wording easy to
understand and complete. An item-tracking grid was constructed to summarize
item changes and their rationales. CONCLUSIONS: Participant feedback indicates
that the concepts of greatest importance in determining COPD inhaler device pref-
erence related to ease of use were reflected in the final CDPQ items.
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OBJECTIVES: Sleep issues are relevant to women across their whole lifespan and
this is especially true during the climacteric period. Previous studies have demon-
strated that insomnia influences quality of life (QOL) across various different do-
mains. However, the different characteristics of the insomnia that influences the
QOL remain unclear. Our study was designed to investigate which type of insomnia
influences the health-related quality of life amongst women. METHODS: A total of
1098 women age between 40-60 years seeking medical advice were drawn from two
hospital, with a further 314 healthy referents of the same age, range and gender,
with no history of hormone replacement therapy and living in the same munici-
pality, also being recruited from a national health survey sample for comparison.
Each one was asked to fill out a brief questionnaire, the Taiwan version of the
World Health Organization Quality of life (WHOQOL-BREF), which assesses quality
of life based on 26 items in four domains (physical, psychological, social and envi-
ronmental). In addition, the Pittsburgh sleep quality index (PSQI) was used to eval-
uate the sleep quality and insomnia pattern of the subjects. Multiple regression
analyses were conducted to control variables such as age, marital status, religion,
educational attainment and menopausal status. RESULTS: The mean total score of
the PSQI was 7.5  3.8 with a range from 0-20. In the 1098 participants, 65.3%
(n717) were confirmed to be poor sleepers, and 34.7% (n381) were good sleepers.
After controlling for the demographic factors, it was found that subjective poor
sleep quality and daytime dysfunction were the major determinants of the scores
in the different domains. CONCLUSIONS: A high incidence of poor sleep quality
exists among climacteric women in the urban area of Taiwan and subjective poor
sleep quality and poor daytime function should be taken into consideration in the
management of climacteric women seeking medical advice.
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VALIDATION OF A PATIENT-REPORTED OUTCOME (PRO) MEASURE AND A
CLINICIAN-REPORTED OUTCOME (CRO) MEASURE TO ASSESS SATISFACTION
AND PREFERENCE WITH PHARMACOLOGICAL STRESS AGENTS FOR SINGLE
PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) MYOCARDIAL
PERFUSION IMAGING (MPI)
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OBJECTIVES: The objective of this study was to validate clinician and patient mea-
sures of satisfaction and preference for pharmacological stress agents (PSAs) used
in Single Photon Emission Computed Tomography (SPECT) Myocardial perfusion
imaging (MPI) procedures using classical and novel psychometric methods.
METHODS: Psychometric validation of the Clinician Satisfaction and Preference
Questionnaire (CSPQ) and the Patient Satisfaction and Preference Questionnaire
(PSPQ) was conducted in a sample of 90 patients and 15 clinicians. Due to the small
sample size, a Bayesian Item Response Theory was utilized to validate the initial
parameter estimates. Specifically, item difficulty was evaluated using patient char-
acteristics as the known prior distributions. RESULTS: The CSPQ demonstrated
strong internal consistency (alpha0.99) and moderate point-biserial correlations
between PSA satisfaction scores and agent preference (range 0.63-0.65). The PSPQ
‘preparation’ and ‘reaction to agent’ scales demonstrated strong internal consis-
tency (alpha0.90 and 0.87 respectively). Test-retest reliability was acceptable for
all PSPQ scales (ICC range0.73 to 0.86). Concurrent validity with the Treatment
Satisfaction Questionnaire for Medication (TSQM) indicate low to moderate corre-
lations between the Effectiveness, Convenience and Global Satisfaction scales of
the TSQM with the PSPQ Satisfaction with Administration, Satisfaction with Effects
and Overall Satisfaction items (range 0.46 to 0.78). The results of the Bayesian
analysis indicated consistency between the two approaches. Specifically, item dif-
ficulty was invariant across the various patient demographics.CONCLUSIONS:The
CSPQ and PSPQ were developed and validated using rigorous, gold standard meth-
odology. The resulting instruments sufficiently represents meaningful domains
demonstrate strong internal consistency, good test-retest reliability, and predic-
tive validity associated with clinician and patient measures of satisfaction and
preference for pharmacological stress agents (PSAs) used in Single Photon Emis-
sion Computed Tomography (SPECT) Myocardial perfusion imaging (MPI) proce-
dures. The variance in the item parameters were fully explained by the summary
demographic information on the patients and physicians as supported by the
Bayesian analysis.
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OBJECTIVES: In CT imaging, as preparation procedure for contrast media (Iopro-
mide), the use of prefilled cartridge (PFC) is simpler compared to glass bottle (GB).
There are several benefits such as infection control and time saving. This study
examined the benefits of contrast media with PFC compared to GB.METHODS: The
benefits are defined as the cost savings which can occur when used in various
situations. A decision analytic model was created to evaluate the effectiveness
according to the type. The use of each type could finally lead to local infection and
blood stream infection (BSI). We estimated the benefits using the probability of
infection from decision model and treatment costs from insurance claims data. To
estimate the benefits of time saving, we measured the preparation time repeatedly
in general hospitals. Assuming that the reduced time was replaced with CT scan in
new patients, we estimated the time saving benefits by multiplying the result to the
cost of CT scan. RESULTS: The material cost of GB was $74.8 which is higher than
$72.9 of PFC. In contrast, in case of GB, the probability of contamination, local
infection and BSI were 3.3%, 1.25%, 0.060% respectively, which were higher than
PFC (0%, 1.22%, 0.058%). The benefit in reduction of infection was estimated at $0.20
per case in PFC. The reduced time from using PFC has an average of 51.9 seconds
based on 113 observations from 3 general hospitals. The time saving benefit was
estimated at $7.16 per case. Therefore, the total benefit was estimated at $7.36.
CONCLUSIONS:This study showed that PFC dominated GB (lower costs, and higher
benefits). This was driven by lower material cost, lower infection risk and admin-
istration time for PFC compared to GB. Findings of this study suggest that the use of
PFC contrast media is an efficient utilization of resources in Korea.
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THE EFFECT OF SUPPLEMENTARY FEES ON THE DIFFUSION OF MEDICAL
DEVICES IN THE GERMAN SYSTEM OF DIAGNOSIS RELATED GROUPS (G-DRG):
THE CASE OF DRUG-ELUTING STENTS IN PATIENTS WITH ACUTE
MYOCARDIAL INFARCTION
Bäumler M
Berlin University of Technology, Berlin, Germany
OBJECTIVES: The aim of the study was to measure the effect of supplementary fees
on the use of drug-eluting stents (DES) in AMI patients instead of conventional
bare-metal stents (BMS). German DRG fees do not distinguish between different
types of coronary stents. To compensate hospitals for higher costs of DES, supple-
mentary payments could be negotiated between the hospital and the sickness
funds.METHODS:Administrative data of one of the largest German sickness funds
was used to identify the determinants of DES use in AMI patients. The dataset
contained information on demographic characteristics and co-morbidities on pa-
tient level. Information on hospital and regional level including the supplementary
fee for the use of DES was merged. 9.453 patients with an admission due to an AMI
and the implantation of a BMS or DES between 2004 through to 2006 were included
in the analysis. For analyzing the data, a logistic multilevel regression approach
was used; the dependent variable was binary, taking the value of 1 if a DES was
implanted and 0 if a BMS was implanted. In the regression, a comprehensive set of
covariates on patient level as well as variables on hospital and regional level were
included. To test robustness of the estimation, several models were estimated.
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